New study tracks immunotherapy side effects to improve patient care

NCT ID NCT03447483

Completed Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Apr 23, 2026 · Last updated May 24, 2026 · Updated 3 times

Summary

This study followed 150 adults with solid tumors who were starting a type of immunotherapy called immune checkpoint inhibitors. Researchers collected data on side effects during each treatment session and asked patients to fill out questionnaires. The goal was to better understand how side effects develop over time, which could help doctors manage them more effectively in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

CH ALBI

Albi, France
Ch Castres

Castres, France
Hopital Larrey

Toulouse, 31059, France
Institut Curie

Paris, 75005, France
Institut Regional Du Cancer de Montpellier (Icm)

Montpellier, 34298, France
Institut Universitaire Du Cancer de Toulouse - Oncopole

Toulouse, 31059, France

Conditions

Explore the condition pages connected to this study.

SOLID TUMOR